This pharmacokinetic limitation poses a significant challenge for its therapeutic application, as only a small fraction of orally administered AC reaches systemic circulation, reducing its efficacy in vivo
Then, 4 L of HiScript III Enzyme Mix was added to the same tube, and reverse transcription was carried out at 50 C for 15 min, followed by enzyme inactivation at 85 C for 5 s
doi: 10.1034/j.1399-5618.2002.01180.xCrossRefGoogle ScholarPubMed Pettegrew, J
Sarcopenia and Its Impact on Anti-obesity Drug Development Sarcopenic obesity, a condition defined by the co-existence of obesity and sarcopenia (loss of muscle mass and function) has emerged as a public health concern, particularly in the aging population
BPC-157, a synthetically produced penta-decapeptide, a fragment of the Body Protective Compound (BPC), protein that was discovered and derived from human gastric juice, represents a sequence of 15 amino acids similar to that present in human BPC